Home DailyMed a146b95d-9b8e-4334-b4b1-987742296ff3 National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 02:21:54 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A061905-001 E.E.S. 400 ERYTHROMYCIN ETHYLSUCCINATE EQ 400MG BASE TABLET / ORAL Approved before 1982 A061905-002 E.E.S. 400 ERYTHROMYCIN ETHYLSUCCINATE EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A061905-002 BX
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 88 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 c2088c7a36db…2026-10-15 13:18:30 2026-09 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 c2088c7a36db…2026-09-14 22:38:34 2026-08 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 84e616aacf4f…2026-09-14 22:38:34 2026-08 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 84e616aacf4f…2026-08-18 06:07:40 2026-07 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A061905-001 E.E.S. 400 EQ 400MG BASE TABLET / ORAL Approved before 1982 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A061905-002 E.E.S. 400 EQ 400MG BASE TABLET / ORAL BX RS 1982-08-12 4b0b4de00fa7…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 44 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join E.E.S 400 ERYTHROMYCIN ETHYLSUCCINATE Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) b455bbdb-a3f1-470f-aa5f-ed83ac2e228d 2023-12-16 Warnings, Adverse reactions Exact identifier ndc (package): 24338-100-13 ndc11 (package): 24338010013
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.